Structure

Physi-Chem Properties

Molecular Weight:  240.09
Volume:  240.23
LogP:  1.851
LogD:  1.411
LogS:  -3.853
# Rotatable Bonds:  0
TPSA:  58.02
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.632
Synthetic Accessibility Score:  2.746
Fsp3:  0.214
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.879
MDCK Permeability:  1.4152871699479874e-05
Pgp-inhibitor:  0.044
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.032
30% Bioavailability (F30%):  0.227

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.553
Plasma Protein Binding (PPB):  87.08895111083984%
Volume Distribution (VD):  1.043
Pgp-substrate:  6.33392858505249%

ADMET: Metabolism

CYP1A2-inhibitor:  0.985
CYP1A2-substrate:  0.564
CYP2C19-inhibitor:  0.546
CYP2C19-substrate:  0.084
CYP2C9-inhibitor:  0.649
CYP2C9-substrate:  0.837
CYP2D6-inhibitor:  0.787
CYP2D6-substrate:  0.753
CYP3A4-inhibitor:  0.26
CYP3A4-substrate:  0.167

ADMET: Excretion

Clearance (CL):  2.114
Half-life (T1/2):  0.328

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.443
Drug-inuced Liver Injury (DILI):  0.693
AMES Toxicity:  0.695
Rat Oral Acute Toxicity:  0.249
Maximum Recommended Daily Dose:  0.722
Skin Sensitization:  0.9
Carcinogencity:  0.953
Eye Corrosion:  0.012
Eye Irritation:  0.626
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471164

Natural Product ID:  NPC471164
Common Name*:   SQGVQVNTJFVDQL-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  SQGVQVNTJFVDQL-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C14H12N2O2/c17-13-8-4-1-2-5-9(8)15-12-10-6-3-7-16(10)14(18)11(12)13/h1-2,4-5,10H,3,6-7H2,(H,15,17)
SMILES:  C1CC2C3=C(C(=O)C4=CC=CC=C4N3)C(=O)N2C1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2385866
PubChem CID:   73353435
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0000056] Quinolones and derivatives
          • [CHEMONTID:0001716] Hydroquinolones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[15730261]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[15973055]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[18656987]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21053938]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. Moroccan n.a. PMID[23713692]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26295595]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[7766039]
NPO19366 Penicillium citrinum Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1864 Cell Line L5178Y Mus musculus IC50 > 10000.0 nM PMID[529577]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471164 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8551 High Similarity NPC316104
0.8551 High Similarity NPC162417
0.8358 Intermediate Similarity NPC254698
0.8188 Intermediate Similarity NPC209389
0.8151 Intermediate Similarity NPC136002
0.8134 Intermediate Similarity NPC179605
0.8134 Intermediate Similarity NPC279385
0.8074 Intermediate Similarity NPC103292
0.806 Intermediate Similarity NPC291962
0.806 Intermediate Similarity NPC177684
0.8 Intermediate Similarity NPC161956
0.8 Intermediate Similarity NPC112373
0.8 Intermediate Similarity NPC258531
0.7945 Intermediate Similarity NPC471574
0.7941 Intermediate Similarity NPC257490
0.7826 Intermediate Similarity NPC469529
0.7762 Intermediate Similarity NPC207428
0.7762 Intermediate Similarity NPC40364
0.7755 Intermediate Similarity NPC207554
0.7754 Intermediate Similarity NPC268534
0.7727 Intermediate Similarity NPC295021
0.7626 Intermediate Similarity NPC39818
0.7622 Intermediate Similarity NPC194562
0.7568 Intermediate Similarity NPC469560
0.755 Intermediate Similarity NPC470822
0.7548 Intermediate Similarity NPC117032
0.7468 Intermediate Similarity NPC237649
0.7468 Intermediate Similarity NPC300596
0.7424 Intermediate Similarity NPC172170
0.7413 Intermediate Similarity NPC322433
0.741 Intermediate Similarity NPC226143
0.7407 Intermediate Similarity NPC279527
0.7407 Intermediate Similarity NPC214960
0.74 Intermediate Similarity NPC130251
0.7394 Intermediate Similarity NPC192533
0.7383 Intermediate Similarity NPC122553
0.7365 Intermediate Similarity NPC300299
0.7351 Intermediate Similarity NPC2823
0.7351 Intermediate Similarity NPC301760
0.7338 Intermediate Similarity NPC324445
0.7317 Intermediate Similarity NPC472118
0.7222 Intermediate Similarity NPC293458
0.7212 Intermediate Similarity NPC471943
0.7178 Intermediate Similarity NPC113056
0.7178 Intermediate Similarity NPC138293
0.7171 Intermediate Similarity NPC315051
0.7169 Intermediate Similarity NPC292265
0.716 Intermediate Similarity NPC475094
0.7143 Intermediate Similarity NPC187231
0.7143 Intermediate Similarity NPC472245
0.7101 Intermediate Similarity NPC57051
0.7099 Intermediate Similarity NPC154478
0.7089 Intermediate Similarity NPC473329
0.7081 Intermediate Similarity NPC84317
0.7052 Intermediate Similarity NPC133003
0.7037 Intermediate Similarity NPC123241
0.7037 Intermediate Similarity NPC222029
0.7032 Intermediate Similarity NPC469537
0.7013 Intermediate Similarity NPC470301
0.7007 Intermediate Similarity NPC72473
0.7007 Intermediate Similarity NPC307437
0.7007 Intermediate Similarity NPC58827
0.6994 Remote Similarity NPC21429
0.6994 Remote Similarity NPC276085
0.6993 Remote Similarity NPC83214
0.6989 Remote Similarity NPC324091
0.6987 Remote Similarity NPC130797
0.6986 Remote Similarity NPC470343
0.6986 Remote Similarity NPC472244
0.6982 Remote Similarity NPC470548
0.6974 Remote Similarity NPC471123
0.6959 Remote Similarity NPC150863
0.6954 Remote Similarity NPC253476
0.6951 Remote Similarity NPC309531
0.6951 Remote Similarity NPC472102
0.6941 Remote Similarity NPC151635
0.6933 Remote Similarity NPC113946
0.6913 Remote Similarity NPC280807
0.6913 Remote Similarity NPC314431
0.6908 Remote Similarity NPC173295
0.6903 Remote Similarity NPC43477
0.6897 Remote Similarity NPC477003
0.6864 Remote Similarity NPC318183
0.6864 Remote Similarity NPC355
0.6854 Remote Similarity NPC476460
0.6845 Remote Similarity NPC224970
0.6845 Remote Similarity NPC167724
0.6845 Remote Similarity NPC223595
0.6839 Remote Similarity NPC470205
0.6832 Remote Similarity NPC66936
0.6829 Remote Similarity NPC104345
0.6829 Remote Similarity NPC61013
0.6818 Remote Similarity NPC87391
0.6807 Remote Similarity NPC469741
0.6788 Remote Similarity NPC193410
0.6788 Remote Similarity NPC36495
0.6784 Remote Similarity NPC475594
0.6782 Remote Similarity NPC197335
0.677 Remote Similarity NPC144691
0.6767 Remote Similarity NPC75496
0.6766 Remote Similarity NPC189116
0.6763 Remote Similarity NPC475761
0.6761 Remote Similarity NPC316141
0.6752 Remote Similarity NPC472241
0.6747 Remote Similarity NPC68650
0.6747 Remote Similarity NPC248117
0.6744 Remote Similarity NPC475607
0.6743 Remote Similarity NPC314659
0.674 Remote Similarity NPC202812
0.6731 Remote Similarity NPC472243
0.6728 Remote Similarity NPC243756
0.6728 Remote Similarity NPC154602
0.6728 Remote Similarity NPC314223
0.6726 Remote Similarity NPC115232
0.6726 Remote Similarity NPC471130
0.6725 Remote Similarity NPC161861
0.6725 Remote Similarity NPC177261
0.6725 Remote Similarity NPC252572
0.6724 Remote Similarity NPC91179
0.6723 Remote Similarity NPC135601
0.6723 Remote Similarity NPC17273
0.6723 Remote Similarity NPC141612
0.6707 Remote Similarity NPC472117
0.6707 Remote Similarity NPC214106
0.6707 Remote Similarity NPC88970
0.6705 Remote Similarity NPC14849
0.6705 Remote Similarity NPC474081
0.6703 Remote Similarity NPC472540
0.6703 Remote Similarity NPC471944
0.6703 Remote Similarity NPC79356
0.6703 Remote Similarity NPC470787
0.6703 Remote Similarity NPC472539
0.6703 Remote Similarity NPC102592
0.6688 Remote Similarity NPC186284
0.6688 Remote Similarity NPC22082
0.6687 Remote Similarity NPC285381
0.6687 Remote Similarity NPC122106
0.6686 Remote Similarity NPC328611
0.6685 Remote Similarity NPC106118
0.6667 Remote Similarity NPC131450
0.6667 Remote Similarity NPC472541
0.6667 Remote Similarity NPC55529
0.6667 Remote Similarity NPC285192
0.6667 Remote Similarity NPC182057
0.6667 Remote Similarity NPC147298
0.6667 Remote Similarity NPC472542
0.6667 Remote Similarity NPC474041
0.6649 Remote Similarity NPC225400
0.6648 Remote Similarity NPC470317
0.6648 Remote Similarity NPC473666
0.6647 Remote Similarity NPC63047
0.6647 Remote Similarity NPC474058
0.6647 Remote Similarity NPC27904
0.6647 Remote Similarity NPC475248
0.6646 Remote Similarity NPC281094
0.6631 Remote Similarity NPC317701
0.6629 Remote Similarity NPC88110
0.6628 Remote Similarity NPC242269
0.6625 Remote Similarity NPC472242
0.6624 Remote Similarity NPC242933
0.6614 Remote Similarity NPC470786
0.6614 Remote Similarity NPC471155
0.6614 Remote Similarity NPC472538
0.661 Remote Similarity NPC97584
0.6609 Remote Similarity NPC284775
0.6609 Remote Similarity NPC186669
0.6607 Remote Similarity NPC286871
0.6607 Remote Similarity NPC472121
0.6604 Remote Similarity NPC308197
0.66 Remote Similarity NPC250476
0.6599 Remote Similarity NPC475915
0.6597 Remote Similarity NPC313673
0.6591 Remote Similarity NPC256452
0.6588 Remote Similarity NPC182131
0.6588 Remote Similarity NPC114637
0.6582 Remote Similarity NPC316202
0.6579 Remote Similarity NPC270241
0.6576 Remote Similarity NPC471199
0.6571 Remote Similarity NPC11126
0.6569 Remote Similarity NPC38262
0.6568 Remote Similarity NPC21174
0.6568 Remote Similarity NPC271797
0.6564 Remote Similarity NPC13526
0.6548 Remote Similarity NPC315368
0.6547 Remote Similarity NPC20322
0.6545 Remote Similarity NPC478076
0.6541 Remote Similarity NPC238499
0.6536 Remote Similarity NPC231382
0.6536 Remote Similarity NPC316746
0.6532 Remote Similarity NPC285622
0.6531 Remote Similarity NPC27833
0.6529 Remote Similarity NPC233380
0.6522 Remote Similarity NPC472293
0.6509 Remote Similarity NPC176983
0.6509 Remote Similarity NPC472120
0.6509 Remote Similarity NPC472101
0.6509 Remote Similarity NPC99632
0.6509 Remote Similarity NPC282339
0.6509 Remote Similarity NPC476231
0.6503 Remote Similarity NPC242000

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471164 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8027 Intermediate Similarity NPD5918 Discontinued
0.7943 Intermediate Similarity NPD486 Clinical (unspecified phase)
0.7941 Intermediate Similarity NPD1124 Approved
0.7941 Intermediate Similarity NPD1123 Approved
0.777 Intermediate Similarity NPD6768 Approved
0.7708 Intermediate Similarity NPD2949 Approved
0.7708 Intermediate Similarity NPD2950 Approved
0.7676 Intermediate Similarity NPD1781 Discontinued
0.7643 Intermediate Similarity NPD1640 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD951 Approved
0.7616 Intermediate Similarity NPD6017 Discontinued
0.7613 Intermediate Similarity NPD2790 Discontinued
0.7582 Intermediate Similarity NPD979 Approved
0.7548 Intermediate Similarity NPD3248 Phase 1
0.7533 Intermediate Similarity NPD6566 Discontinued
0.7518 Intermediate Similarity NPD9541 Approved
0.7518 Intermediate Similarity NPD9539 Approved
0.7483 Intermediate Similarity NPD4464 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD1175 Approved
0.7468 Intermediate Similarity NPD4939 Clinical (unspecified phase)
0.7466 Intermediate Similarity NPD441 Approved
0.7466 Intermediate Similarity NPD6740 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD1619 Phase 3
0.7432 Intermediate Similarity NPD5227 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD9540 Approved
0.741 Intermediate Similarity NPD1306 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD2918 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD2919 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD4942 Approved
0.7347 Intermediate Similarity NPD1541 Approved
0.7347 Intermediate Similarity NPD1527 Phase 2
0.731 Intermediate Similarity NPD4549 Discontinued
0.7305 Intermediate Similarity NPD5840 Discontinued
0.7279 Intermediate Similarity NPD1920 Approved
0.7279 Intermediate Similarity NPD1919 Approved
0.7267 Intermediate Similarity NPD6342 Discontinued
0.7256 Intermediate Similarity NPD2404 Discontinued
0.7256 Intermediate Similarity NPD2413 Phase 2
0.7254 Intermediate Similarity NPD4775 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD2331 Discontinued
0.7237 Intermediate Similarity NPD3434 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD7072 Phase 2
0.7226 Intermediate Similarity NPD1524 Phase 1
0.7218 Intermediate Similarity NPD1064 Approved
0.7218 Intermediate Similarity NPD1065 Approved
0.7212 Intermediate Similarity NPD3376 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD33 Approved
0.7205 Intermediate Similarity NPD4393 Approved
0.7188 Intermediate Similarity NPD6855 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD1079 Discontinued
0.7172 Intermediate Similarity NPD797 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2431 Approved
0.7169 Intermediate Similarity NPD2432 Approved
0.7161 Intermediate Similarity NPD5933 Phase 3
0.7161 Intermediate Similarity NPD5932 Phase 3
0.7161 Intermediate Similarity NPD5931 Phase 3
0.7152 Intermediate Similarity NPD2037 Approved
0.7125 Intermediate Similarity NPD4045 Phase 2
0.7125 Intermediate Similarity NPD4042 Phase 2
0.7124 Intermediate Similarity NPD2010 Phase 3
0.7118 Intermediate Similarity NPD4329 Approved
0.7118 Intermediate Similarity NPD4330 Approved
0.7107 Intermediate Similarity NPD1854 Approved
0.7105 Intermediate Similarity NPD7254 Discontinued
0.7101 Intermediate Similarity NPD3792 Approved
0.7092 Intermediate Similarity NPD1668 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD5748 Phase 2
0.7059 Intermediate Similarity NPD3782 Discontinued
0.7048 Intermediate Similarity NPD2454 Approved
0.7048 Intermediate Similarity NPD2455 Approved
0.7039 Intermediate Similarity NPD6358 Phase 2
0.7032 Intermediate Similarity NPD5024 Approved
0.7013 Intermediate Similarity NPD3625 Discontinued
0.7013 Intermediate Similarity NPD1222 Discontinued
0.7 Intermediate Similarity NPD1323 Discontinued
0.6993 Remote Similarity NPD7142 Discontinued
0.6988 Remote Similarity NPD4645 Clinical (unspecified phase)
0.6968 Remote Similarity NPD2365 Approved
0.6964 Remote Similarity NPD5727 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2506 Approved
0.6948 Remote Similarity NPD5068 Clinical (unspecified phase)
0.6928 Remote Similarity NPD4077 Clinical (unspecified phase)
0.6923 Remote Similarity NPD2820 Phase 3
0.6919 Remote Similarity NPD3989 Phase 3
0.6917 Remote Similarity NPD708 Approved
0.6883 Remote Similarity NPD1626 Approved
0.6883 Remote Similarity NPD6655 Clinical (unspecified phase)
0.6879 Remote Similarity NPD3470 Approved
0.6879 Remote Similarity NPD3471 Approved
0.6879 Remote Similarity NPD3990 Phase 3
0.6871 Remote Similarity NPD1663 Discontinued
0.6857 Remote Similarity NPD5179 Approved
0.6857 Remote Similarity NPD5180 Approved
0.6857 Remote Similarity NPD5181 Approved
0.6852 Remote Similarity NPD2360 Approved
0.6813 Remote Similarity NPD5942 Approved
0.6813 Remote Similarity NPD5941 Approved
0.6788 Remote Similarity NPD2427 Approved
0.6784 Remote Similarity NPD2461 Phase 1
0.677 Remote Similarity NPD2737 Clinical (unspecified phase)
0.6763 Remote Similarity NPD2590 Clinical (unspecified phase)
0.6761 Remote Similarity NPD2397 Discontinued
0.676 Remote Similarity NPD5592 Clinical (unspecified phase)
0.6746 Remote Similarity NPD3468 Approved
0.6744 Remote Similarity NPD2083 Clinical (unspecified phase)
0.6744 Remote Similarity NPD3978 Clinical (unspecified phase)
0.6744 Remote Similarity NPD4091 Approved
0.6739 Remote Similarity NPD1342 Approved
0.6725 Remote Similarity NPD7443 Clinical (unspecified phase)
0.6712 Remote Similarity NPD3836 Clinical (unspecified phase)
0.6709 Remote Similarity NPD1625 Approved
0.6705 Remote Similarity NPD4092 Approved
0.6705 Remote Similarity NPD3994 Approved
0.6705 Remote Similarity NPD8241 Phase 2
0.6705 Remote Similarity NPD3995 Approved
0.6705 Remote Similarity NPD3991 Approved
0.6705 Remote Similarity NPD3993 Approved
0.6705 Remote Similarity NPD3996 Approved
0.6705 Remote Similarity NPD3992 Approved
0.669 Remote Similarity NPD851 Approved
0.669 Remote Similarity NPD853 Approved
0.669 Remote Similarity NPD1217 Clinical (unspecified phase)
0.6689 Remote Similarity NPD5131 Approved
0.6688 Remote Similarity NPD4461 Discontinued
0.6688 Remote Similarity NPD2791 Discontinued
0.6687 Remote Similarity NPD6629 Discontinued
0.6686 Remote Similarity NPD3522 Approved
0.6686 Remote Similarity NPD7662 Clinical (unspecified phase)
0.6685 Remote Similarity NPD3246 Discontinued
0.6667 Remote Similarity NPD3481 Approved
0.6667 Remote Similarity NPD3790 Phase 2
0.6667 Remote Similarity NPD3079 Approved
0.6667 Remote Similarity NPD5504 Discontinued
0.6667 Remote Similarity NPD3076 Approved
0.6667 Remote Similarity NPD3997 Approved
0.6667 Remote Similarity NPD1874 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3884 Discontinued
0.6667 Remote Similarity NPD3078 Approved
0.6667 Remote Similarity NPD3998 Approved
0.6667 Remote Similarity NPD3999 Approved
0.6667 Remote Similarity NPD4043 Approved
0.6667 Remote Similarity NPD941 Approved
0.6667 Remote Similarity NPD4046 Approved
0.6667 Remote Similarity NPD3077 Approved
0.6646 Remote Similarity NPD1189 Approved
0.6646 Remote Similarity NPD6513 Approved
0.6646 Remote Similarity NPD6512 Approved
0.6645 Remote Similarity NPD4300 Clinical (unspecified phase)
0.6645 Remote Similarity NPD2754 Discontinued
0.6629 Remote Similarity NPD7014 Clinical (unspecified phase)
0.6627 Remote Similarity NPD8630 Approved
0.6621 Remote Similarity NPD922 Approved
0.662 Remote Similarity NPD3387 Approved
0.6612 Remote Similarity NPD4848 Phase 1
0.6609 Remote Similarity NPD7587 Clinical (unspecified phase)
0.6608 Remote Similarity NPD2369 Discontinued
0.6608 Remote Similarity NPD5186 Approved
0.6608 Remote Similarity NPD5183 Approved
0.6607 Remote Similarity NPD7220 Approved
0.6604 Remote Similarity NPD4430 Phase 2
0.6604 Remote Similarity NPD5527 Clinical (unspecified phase)
0.6604 Remote Similarity NPD5526 Phase 2
0.66 Remote Similarity NPD1321 Clinical (unspecified phase)
0.6592 Remote Similarity NPD4988 Discontinued
0.6584 Remote Similarity NPD1956 Clinical (unspecified phase)
0.6581 Remote Similarity NPD1410 Phase 1
0.6576 Remote Similarity NPD7572 Phase 2
0.6575 Remote Similarity NPD3304 Phase 2
0.6562 Remote Similarity NPD4347 Clinical (unspecified phase)
0.6552 Remote Similarity NPD1544 Phase 1
0.6552 Remote Similarity NPD2638 Clinical (unspecified phase)
0.6549 Remote Similarity NPD480 Approved
0.6547 Remote Similarity NPD1054 Approved
0.6545 Remote Similarity NPD737 Phase 2
0.6545 Remote Similarity NPD7612 Clinical (unspecified phase)
0.6544 Remote Similarity NPD813 Approved
0.6543 Remote Similarity NPD1802 Approved
0.6543 Remote Similarity NPD7088 Discontinued
0.6543 Remote Similarity NPD1801 Approved
0.6538 Remote Similarity NPD7786 Discontinued
0.6536 Remote Similarity NPD1190 Approved
0.6532 Remote Similarity NPD5997 Discontinued
0.6532 Remote Similarity NPD3377 Discontinued
0.6532 Remote Similarity NPD3868 Phase 1
0.6529 Remote Similarity NPD3850 Clinical (unspecified phase)
0.6528 Remote Similarity NPD1025 Discontinued
0.6517 Remote Similarity NPD4412 Phase 2
0.6503 Remote Similarity NPD4888 Discontinued
0.65 Remote Similarity NPD2129 Approved
0.649 Remote Similarity NPD1593 Approved
0.6486 Remote Similarity NPD3828 Approved
0.6484 Remote Similarity NPD6180 Clinical (unspecified phase)
0.6483 Remote Similarity NPD1344 Phase 2
0.648 Remote Similarity NPD6557 Phase 2
0.648 Remote Similarity NPD3413 Approved
0.648 Remote Similarity NPD3414 Approved
0.6479 Remote Similarity NPD3865 Approved
0.6477 Remote Similarity NPD2869 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6318 Clinical (unspecified phase)
0.6474 Remote Similarity NPD2470 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data